ClearPoint Neuro is joining forces with Blackrock Microsystems to further develop the two's presence in the neuroscience market.
Blackrock is known for its implantable electrode arrays, and the two firms expect initial product launches in 2023, starting with the Microelectric Recording (MER) platform. After that, they plan to create "smart" biopsy needles and other implantable neural electrodes.
Eventually, ClearPoint Neuro and Blackrock will move beyond the MRI suite and into the operating room, they said in a press release.
